Found: 12
Select item for more details and to access through your institution.
Immunophenotypic but Not Genetic Changes Reclassify the Majority of Relapsed/Refractory Pediatric Cases of Early T-Cell Precursor Acute Lymphoblastic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 5610, doi. 10.3390/ijms25115610
- By:
- Publication type:
- Article
A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5547, doi. 10.3390/cancers15235547
- By:
- Publication type:
- Article
Flow cell sorting followed by PCR‐based clonality testing may assist in questionable diagnosis and monitoring of acute lymphoblastic leukemia.
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 4, p. 506, doi. 10.1111/ijlh.14053
- By:
- Publication type:
- Article
Correlation of the surface expression of thymic stromal lymphopoietin receptor with the presence of CRLF2 gene rearrangements in children with B‐lineage acute lymphoblastic leukemia.
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 3, p. 337, doi. 10.1111/ijlh.14028
- By:
- Publication type:
- Article
Molecular heterogeneity of pediatric choroid plexus carcinomas determines the distinctions in clinical course and prognosis.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 6, p. 1132, doi. 10.1093/neuonc/noac274
- By:
- Publication type:
- Article
Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 3, p. 510, doi. 10.1111/bjh.18021
- By:
- Publication type:
- Article
Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5445, doi. 10.3390/cancers14215445
- By:
- Publication type:
- Article
B‐lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting.
- Published in:
- Cytometry. Part B, 2022, v. 102, n. 5, p. 353, doi. 10.1002/cyto.b.22088
- By:
- Publication type:
- Article
Strong expansion of normal CD19‐negative B‐cell precursors after the use of blinatumomab in the first‐line therapy of acute lymphoblastic leukaemia in children.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. e6, doi. 10.1111/bjh.17760
- By:
- Publication type:
- Article
Prognostic value of minimal residual disease measured by fusion‐gene transcript in infants with KMT2A‐rearranged acute lymphoblastic leukaemia treated according to the MLL‐Baby protocol.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 6, p. 1151, doi. 10.1111/bjh.17304
- By:
- Publication type:
- Article
Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 5, p. 1331, doi. 10.1007/s00432-019-02886-3
- By:
- Publication type:
- Article
Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 4, p. 1001, doi. 10.1007/s00432-019-02854-x
- By:
- Publication type:
- Article